Recombinant Human ANGPTL4 Protein，His

Angiopoietin-like 4 (ANGPTL4) is a secreted glycoprotein implicated in a variety of physiological and pathological processes, particularly in metabolism, inflammation, and tumor biology. Initially identified as a regulator of angiogenesis, ANGPTL4 is now known to play critical roles in lipid metabolism by inhibiting lipoprotein lipase, thereby affecting triglyceride levels in the bloodstream. This is particularly relevant in metabolic disorders such as obesity and diabetes. Additionally, ANGPTL4 has been associated with cancer progression and metastasis, highlighting its potential as a therapeutic target. Studies have shown that ANGPTL4 expression levels can be modulated by various factors, including hypoxia and inflammatory cytokines, indicating its role in adaptive responses to tissue microenvironments. The recombinant protein variant of ANGPTL4 has garnered attention for its potential applications in both diagnostics and therapeutics. Understanding the precise mechanisms of ANGPTL4 action through recombinant protein studies can provide insights into its multifaceted roles and open avenues for novel interventions in metabolic and oncological diseases. Given the increasing prevalence of related health issues, ongoing research aims to elucidate the signaling pathways and interaction networks associated with ANGPTL4, which may ultimately facilitate the development of more effective treatments and management strategies.